Sinemet supply problems

MSD has warned that the availability of Sinemet (levodopa/carbidopa) will be reduced from late 2009 until 2011.

The global shortage of the Parkinson’s disease treatment, which is due to a change in supply source, will affect all presentations of Sinemet, Sinemet CR and Half Sinemet CR.

View Sinemet drug record

Further information: MSD

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more